Skip to content
10-K/A

Annual Report

NUTEX HEALTH INC. NUTX

0001628280-25-052895

← back to feed
Filed
Nov 18, 2025 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding restated FY 2024 · Mar 24, 2025 5.95M sh
Shares Diluted restated FY 2024 · Dec 31, 2024 5.49M sh
Shares Diluted FY 2024 · Dec 31, 2023 4.41M sh
Shares Diluted FY 2024 · Dec 31, 2022 4.23M sh
Capex restated FY 2024 · Dec 31, 2024 $2.3M
Capex restated FY 2024 · Dec 31, 2023 $9.5M
Capex FY 2024 · Dec 31, 2022 $14.63M
Operating Cash Flow restated FY 2024 · Dec 31, 2024 $23.15M
Operating Cash Flow restated FY 2024 · Dec 31, 2023 $1.26M
Operating Cash Flow FY 2024 · Dec 31, 2022 $50.61M
Long Term Debt restated FY 2024 · Dec 31, 2024 $22.47M
Long Term Debt FY 2024 · Dec 31, 2023 $26.31M
Cash And Equivalents restated FY 2024 · Dec 31, 2024 $40.64M
Cash And Equivalents restated FY 2024 · Dec 31, 2023 $22M
Stockholders Equity restated FY 2024 · Dec 31, 2024 $132.44M
Stockholders Equity FY 2024 · Dec 31, 2023 $61.45M
Current Liabilities restated FY 2024 · Dec 31, 2024 $154.23M
Current Liabilities FY 2024 · Dec 31, 2023 $58.31M
Total Liabilities restated FY 2024 · Dec 31, 2024 $466.79M
Total Liabilities FY 2024 · Dec 31, 2023 $319.14M
Current Assets restated FY 2024 · Dec 31, 2024 $292.48M
Current Assets FY 2024 · Dec 31, 2023 $90.85M
Total Assets restated FY 2024 · Dec 31, 2024 $655.32M
Total Assets FY 2024 · Dec 31, 2023 $398.25M
Eps Diluted restated FY 2024 · Dec 31, 2024 $9.69
Eps Diluted restated FY 2024 · Dec 31, 2023 −$10.39
Eps Diluted restated FY 2024 · Dec 31, 2022 −$100.36
Eps Basic restated FY 2024 · Dec 31, 2024 $10.23
Eps Basic restated FY 2024 · Dec 31, 2023 −$10.39
Eps Basic restated FY 2024 · Dec 31, 2022 −$100.36
Sga Expense restated FY 2024 · Dec 31, 2024 $41.92M
Sga Expense restated FY 2024 · Dec 31, 2023 $33.23M
Sga Expense restated FY 2024 · Dec 31, 2022 $19.81M
Net Income restated FY 2024 · Dec 31, 2024 $52.1M
Net Income restated FY 2024 · Dec 31, 2023 −$45.79M
Net Income FY 2024 · Dec 31, 2022 −$424.78M
Operating Income restated FY 2024 · Dec 31, 2024 $130.7M
Operating Income restated FY 2024 · Dec 31, 2023 −$31.77M
Operating Income FY 2024 · Dec 31, 2022 −$406.6M
Gross Profit restated FY 2024 · Dec 31, 2024 $196.26M
Gross Profit restated FY 2024 · Dec 31, 2023 $34.77M
Gross Profit restated FY 2024 · Dec 31, 2022 $15.42M